PAVmed, Inc. (PAVM)
2.79
+0.10
(+3.72%)
USD |
NASDAQ |
Oct 09, 16:00
2.79
0.00 (0.00%)
After-Hours: 20:00
PAVmed Enterprise Value : 18.88M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 18.88M |
| October 08, 2026 | 18.26M |
| October 07, 2026 | 18.57M |
| October 06, 2026 | 18.16M |
| October 05, 2026 | 18.07M |
| October 02, 2026 | 19.39M |
| October 01, 2026 | 18.32M |
| September 30, 2026 | 24.53M |
| September 29, 2026 | 25.31M |
| September 28, 2026 | 25.19M |
| September 25, 2026 | 25.50M |
| September 24, 2026 | 25.72M |
| September 23, 2026 | 26.39M |
| September 22, 2026 | 27.61M |
| September 21, 2026 | 26.28M |
| September 18, 2026 | 26.22M |
| September 17, 2026 | 26.28M |
| September 16, 2026 | 25.97M |
| September 15, 2026 | 25.97M |
| September 14, 2026 | 28.92M |
| September 11, 2026 | 27.60M |
| September 10, 2026 | 28.16M |
| September 09, 2026 | 29.73M |
| September 08, 2026 | 30.98M |
| September 04, 2026 | 34.50M |
| Date | Value |
|---|---|
| September 03, 2026 | 33.30M |
| September 02, 2026 | 34.93M |
| September 01, 2026 | 32.68M |
| August 31, 2026 | 34.06M |
| August 28, 2026 | 32.24M |
| August 27, 2026 | 33.18M |
| August 26, 2026 | 34.75M |
| August 25, 2026 | 34.46M |
| August 24, 2026 | 33.37M |
| August 21, 2026 | 33.84M |
| August 20, 2026 | 33.87M |
| August 19, 2026 | 33.37M |
| August 18, 2026 | 33.12M |
| August 17, 2026 | 34.78M |
| August 14, 2026 | 33.99M |
| August 13, 2026 | 31.11M |
| August 12, 2026 | 27.79M |
| August 11, 2026 | 30.92M |
| August 10, 2026 | 31.17M |
| August 07, 2026 | 31.11M |
| August 06, 2026 | 32.36M |
| August 05, 2026 | 32.99M |
| August 04, 2026 | 32.99M |
| August 03, 2026 | 35.87M |
| July 31, 2026 | 32.43M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 200.00B |
| AngioDynamics, Inc. | 465.50M |
| Alphatec Holdings, Inc. | 2.138B |
| AtriCure, Inc. | 2.745B |
| Baxter International, Inc. | 19.27B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.598M |
| Revenue (Quarterly) | 0.033M |
| Total Expenses (Quarterly) | 5.417M |
| EPS Diluted (Quarterly) | -0.8739 |
| Gross Profit Margin (Quarterly) | -327.3% |
| Profit Margin (Quarterly) | -19.99K% |
| Earnings Yield | -590.3% |
| Normalized Earnings Yield | -465.84 |